1,639
Views
13
CrossRef citations to date
0
Altmetric
Review: Extracorporeal organ support

Mechanical circulatory support

&
Pages 50-63 | Published online: 01 Jan 2011

References

  • Lillehei CW, Dewall RA, Read RC, Warden HE, Varco RL. Direct vision intracardiac surgery in man using a simple, disposable artificial oxygenator. Dis Chest 1956; 29:1 - 8
  • DeBakey ME. Development of mechanical heart devices. Ann Thorac Surg 2005; 79:2228 - 2231
  • Gemmato CJ, Forrester MD, Myers TJ, Frazier OH, Cooley DA. Thirty-Five years of mechanical circulatory support at the Texas Heart Institute. Tex Heart Inst J 2005; 32:168 - 177
  • Mudge GH Jr, Fang JC, Smith C, Couper G. The physiologic basis for the management of ventricular assist devices. Clin Cardiol 2006; 29:285 - 289
  • Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin H, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995; 222:337 - 338
  • Dang NC, Topkara VK, Kim BT, Mercando ML, Kay J, Naka Y. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation. J Thorac Cardiovasc Surg 2005; 130:1302 - 1309
  • Bank AJ, Mir SH, Nguyen DQ, Bolman RM, Shumway SJ, Miller LW, et al. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg 2000; 69:1369 - 1374
  • Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term mechanical left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345:1435 - 1443
  • Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003; 125:855 - 862
  • Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL Jr. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968; 203:113 - 118
  • Papaioannou TG, Stefanadis C. Basic principles of the intraaortic balloon pump and mechanisms affecting its performance. ASAIO 2005; 51:296 - 300
  • Baughman KL, Jarcho JA. Bridge to life—cardiac mechanical support. N Engl J Med 2007; 357:846 - 849
  • Kar B, Adkins LE, Civitello AB, Loyalka P, Palanichamy N, Gemmato CJ, et al. Clinical experience with the TandemHeart® percutaneous ventricular assist device. Tex Heart Inst J 2006; 33:111 - 115
  • Wheeldon DR. Mechanical circulatory support: state of the art and future perspectives. Perfusion 2003; 18:159 - 169
  • Samoukovic G, Rosu C, Giannetti N, Cecere R. The Impella® LP 5.0 as a bridge to long-term circulatory support. Interact CardioVasc Thorac Surg 2009; 8:682 - 683
  • Litwak KN, Kihara S, Kameneva MV, Litwak P, Uryash A, Wu Z, et al. Effects of continuous flowlLeft ventricular assist device support on skin tissue microcirculation and aortic hemodynamics. ASAIO Journal 2003; 49:103 - 107
  • Ootaki Y, Kamohara K, Akiyama M, Zahr F, Kopcak MW, Dessoffy R, et al. Phasic coronary blood flow pattern during a continuous flow left ventricular assist support. Eur J Cardiothorac Surg 2005; 28:711 - 716
  • Letsou GV, Myers TJ, Gregoric ID, Delgado R, Shah N, Robertson K, et al. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg 2003; 76:1167 - 1170
  • Saito S, Westaby S, Piggot D, Dudnikov S, Robson D, Catarino PA, et al. End-organ function during chronic nonpulsatile circulation. Ann Thorac Surg 2002; 74:1080 - 1085
  • Thohan V, Stetson SJ, Nagueh SF, Rivas-Gotz C, Koerner MM, Lafuente JA, et al. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant 2005; 24:566 - 575
  • Zimpfer D, Wieselthaler G, Czerny M, Fakin R, Haider D, Zrunek P, et al. Neurocognitive function in patients with ventricular assist devices: a comparison of pulsatile and continuous blood flow devices. ASAIO J 2006; 52:24 - 27
  • Sezai A, Shiono M, Orime Y, Nakata K, Hata M, Iida M, et al. Major organ function under mechanical support: comparative studies of pulsatile and nonpulsatile circulation. Artificial Organs 1999; 23:280 - 285
  • Reddy RC, Goldstein AH, Pacella JJ, Cattivera GR, Clark RE, Magovern GJ Sr. End organ function with prolonged nonpulsative circulatory support. ASAIO J 1995; 41:547 - 551
  • Simon MA, Watson J, Baldwin JT, Wagner WR, Borovetz HS. Current and future considerations in the use of mechanical circulatory support devices. Annu Rev Biomed Eng 2008; 10:59 - 84
  • Slater JP, Rose EA, Levin HR, Frazier OH, Roberts JK, Weinberg AD, et al. Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist device. Ann Thorac Surg 1996; 62:1321 - 1328
  • Mehta SM, Pae WE Jr, Rosenberg G, Snyder AJ, Weiss WJ, Lewis JP, et al. The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg 2001; 71:156 - 161
  • Noon GP, Morley DL, Irwin S, Abdelsayed SV, Benkowski RJ, Lynch BE. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg 2001; 71:133 - 138
  • Frazier OH, Myers TJ, Jarvik RK, Westaby S, Pigott DW, Gregoric ID, et al. Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart. Ann Thorac Surg 2001; 71:125 - 132
  • Loforte A, Montallo A, Ranocchi F, Casali G, Luzi G, Della Monica PL, et al. Long-term mechanical support with the HeartMate® II LVAS. Transplant Proc 2009; 41:1357 - 1359
  • Frazier OH, Gemmato C, Myers TJ, Gregoric ID, Radovancevic P, Loyalka P, et al. Initial clinical experience with the HeartMate® II Axial-Flow left ventricular assist device. Tex Heart Inst J 2007; 34:275 - 281
  • Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357:885 - 896
  • Schmid C, Tjan TD, Etz C, Scmidt C, Wenzelburger F, Wilhelm M, et al. First clinical experience with the Incor left ventricular assist device. J Heart Lung Transplant 2005; 24:1188 - 1194
  • Esmore DS, Kaye D, Salamonsen R, Buckland M, Rowland M, Negri J, et al. First clinical implant of the VentrAssist Left Ventricular Assist System as destination therapy for end-stage heart failure. J Heart Lung Transplant 2005; 24:1150 - 1154
  • Esmore D, Spratt P, Larbalestier R, Tsui S, Fiane A, Ruygrok P, et al. VentrAssist™ left ventricular assist device: clinical trial results and Clinical Development Plan update. Eur J Cardiothorac Surg 2007; 32:735 - 744
  • Esmore D, Kaye D, Spratt P, Larbalesteir R, Ruygrok P, Tsui S, et al. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant 2008; 27:579 - 588
  • Farrar DJ, Bourque K, Dague CP, Cotter CJ, Poirier VL. Design features, development status and experimental results with the Heartmate III centrifugal left ventricular assist system with a magnetically levitated rotor. ASAIO Journal 2007; 53:310 - 315
  • Loree HM II, Bourque K, Gernes DB, Richardson JS, Poirier VL, Barletta N, et al. The HeartMate III: Design and in vivo studies of a Maglev centrifugal left ventricular assist device. Artificial Organs 25:386 - 391
  • Komoda T, Weng Y, Nojiri C, Hetzer R. Implantation technique for the DuraHeart left ventricular assist system. J Artif Organs 2007; 10:124 - 127
  • Horvath DJ, Golding LAR, Massiello A, Medvedev AL, Gerhart RL, Ochiai T, et al. The CorAide blood pump. Ann Thorac Surg 2001; 71:191
  • Gazzoli F, Alloni A, Pagani F, Pellegrini C, Longobardi A, Ricci D, et al. Arrow CorAide Left Ventricular Assist System: initial experience of the cardiothoracic surgery center in Pavia. Ann Thorac Surg 2007; 83:279 - 282
  • Tuzun E, Roberts K, Cohn WE, Sargin M, Gemmato CJ, Radovancevic B, et al. In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J 2007; 34:406 - 411
  • Wood C, Maiorana A, Larbalestier R, Lovett M, Green G, O'Driscoll G. First successful bridge to myocardial recovery with a HeartWare HVAD. J Heart Lung Transplant 2008; 27:695 - 697
  • Spanier T, Oz M, Levin H, Weinberg A, Stamatis K, Stern D. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 1996; 112:1090 - 1097
  • Holman WL, Park SJ, Long JW, Weinberg A, Gupta L, Tierney AR, et al. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 2004; 23:1359 - 1365
  • Holman WL, Skinner JL, Waites KB, Benza RL, McGiffin DC, Kirklin JK. Infection during circulatory support with ventricular assist devices. Ann Thorac Surg 1999; 68:711 - 716
  • Holman WL, Rayburn BK, McGiffin DC, Foley BA, Benza RL, Bourge RC, et al. Infection in ventricular assist devices: prevention and treatment. Ann Thorac Surg 2003; 75:48 - 57
  • Nurozler F, Argenziano M, Oz MC, Naka Y. Fungal left ventricular assist device endocarditis. Ann Thorac Surg 2001; 71:614 - 618
  • Chinn R, Dembitsky W, Eaton L, Chillcott S, Stahovich M, Rasmusson B, et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J 2005; 51:461 - 470
  • Minami K, El-Banayosy A, Sezai A, Arusoglu L, Sarnowsky P, Fey O, et al. Morbidity and outcome after mechanical ventricular support using Thoratec, Novacar and HeartMate for bridging to heart transplantation. Artif Organs 24:421 - 426
  • Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998; 339:1522 - 1533
  • Dang NC, Topkara VK, Mercnado M, Kay J, Krugger KH, Aboodi MS, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006; 25:1 - 6
  • Kavarana MN, Pessin-Minsley MS, Urtecho J, Catanese KA, Flannery M, Oz MC, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 2002; 73:745 - 750
  • Morgan JA, John R, Lee BJ, Oz MC, Naka Y. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004; 77:859 - 863
  • Santamore WP, Gray LA. Left ventricular contributions to right ventricular systolic function during LVAD support. Ann Thorac Surg 1996; 61:350 - 356
  • Van Meter CH Jr. Right heart failure: Best treated by avoidance. Ann Thorac Surg 2001; 71:220 - 222
  • Argenziano M, Choudhri AF, Moazami N, Rose EA, Smith CR, Levin HR, et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg 1998; 65:340 - 345
  • Dembitsky WP, Tector AJ, Park S, Moskowitz AJ, Gelijins AC, Ronan NS, et al. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH Trial. Ann Thorac Surg 2004; 78:2123 - 2130
  • Cooley DA. The total artificial heart. Nat Med 2003; 9:108 - 111
  • Gray NA Jr, Selzman CH. Current status of the total artificial heart. Am Heart J 2006; 152:4 - 10
  • Frazier OH, Akutsu T, Cooley DA. Total artificial heart (TAH) utilization in man. Trans Am Soc Artif Intern Organs 1982; 28:534 - 538
  • DeVries WC. The permanent artificial heart, four case reports. JAMA 1988; 259:849 - 859
  • DeVries WC, Anderson JL, Joyce LD, Anderson FL, Hammond EH, Jarvik RK, et al. Clinical use of the total artificial heart. N Engl J Med 1984; 310:273 - 278
  • Griffith BP, Hardesty RL, Kormos RL, Trento A, Borovetz HS, Thompson ME, et al. Temporary use of the Jarvik-7 total artificial heart before transplantation. N Engl J Med 1987; 316:130 - 134
  • Copeland JG, Smith RG, Icenogle TB, Rhenman B, Williams R, Vasu MA. Early experience with the total artificial heart as a bridge to cardiac transplantation. Surg Clin North Am 1988; 68:621 - 635
  • Johnson KE, Prieto M, Joyce LD, Pritzker M, Emery RW. Summary of the clinical use of the Symbion total artificial heart: a registry report. J Heart Lung Transplant 1992; 11:103 - 116
  • Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi Gk, Tsau PH, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 2004; 351:859 - 867
  • SoRelle R. Totally contained AbioCor artificial heart implanted July 3, 2001. Circulation 2001; 104:9005 - 9006
  • Mussivand T, Holmes KS, Hum a, Keon WJ. Transcutaneous energy transfer with voltage regulation for rotary blood pumps. Artif Organs 1996; 20:621 - 624
  • Ahn JM, Kang DW, Kim HC, Min BG. In Vivo performance evaluation of a transcutaneous energy and information transmission system for the total artificial heart. ASAIO Journal 1993; 39:208 - 212
  • Dowling RD, Etoch SW, Stevens KA, Johnson AC, Gray LA Jr. Current status of the AbioCor Implantable Replacement Heart. Ann Thorac Surg 2001; 71:147 - 149
  • Copeland JG, Smith RG, Bose RK, Tsau PH, Nolan PE, Slepian MJ. Risk factor analysis for bridge to transplantation with the CardioWest Total Artificial Heart. Ann Thorac Surg 2008; 85:1639 - 1644
  • Dowling RD, Gray LA Jr, Etoch SW, Laks H, Marelli D, Samuels L, et al. Initial experience with the AbioCor Implantable Replacement Heart System. J Thorac Cardiovasc Surg 2004; 127:131 - 141
  • Quaini E, Pavie A, Chieco S, Mambrito B. The Concerted Action ‘Heart’ European registry on clinical application of mechanical circulatory support systems: bridge to transplant. The Registry Scientific Committee. Eur J Cardiothorac Surg 1997; 11:182 - 188
  • Mehta SM, Aufiero TX, Pae WE Jr, Miller CA, Pierce WS. Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation: sixth official report. J Heart Lung Transplant 1995; 14:585 - 593
  • Conger JL, Inman RW, Tamez D, Frazier OH, Branislav R. Infection and thrombosis in total artificial heart technology: past and future challenges-a historical review. ASAIO J 2000; 46:22 - 27
  • Copeland JG, Pavie A, Duveau D, Keon WJ, Masters R, Pifarre R, et al. Bridge to transplantation with the CardioWest Total Artificial Heart: The international experience 1993 to 1995. J Heart Lung Transplant 1996; 15:94 - 99
  • Copeland JG, Smith RG, Arabia FA, Nolan PE, Mehta VK, McCarthy MS, et al. Comparison of the CardioWest Total Artificial Heart, the Novacor Left Ventricular Assist System and the Thoractec Ventricular Assist System in bridge to transplantation. Ann Thorac Surg 2001; 71:92 - 97
  • Didisheim P, Olsen DB, Farrar DJ, Portner PM, Griffith BP, Pennington DG, et al. Infections and thromboembolism with implantable cardiovascular devices. Trans Am Soc Artif Intern Organs 1989; 35:54 - 70
  • Chen YS, Yu HY, Huang SC, Chiu KM, Lin TY, Lai LP, et al. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first?. J Heart Lung Transplant 2005; 24:81 - 87
  • Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001; 122:440 - 448
  • Grinda JM, Chevalier P, D'Attellis N, Bricourt MO, Berrebi A, Guibourt P, et al. Fulminant myocarditis in adults and children: bi-ventricular assist device for recovery. Eur J Cardiothorac Surg 2004; 26:1169 - 1173
  • Goldman AP, Cassidy J, de Leval M, Haynes S, Brown K, Whitmore P, et al. The waiting game: bridging to paediatric heart transplantation. Lancet 2003; 362:1948 - 1949
  • Webber S. Clinical Trials Working Group. Pediatric circulatory support contractors' meeting: Report of the Clinical Trials Working Group. ASAIO J 2009; 55:10 - 12
  • Baldwin JT, Borovetz HS, Duncan BW, Gartner MJ, Jarvik RK, Weiss WJ, Hoke TR. The National Heart, Lung and Blood Institute Pediatric Circulatory Support Program. Circulation 2006; 113:147 - 155
  • Thoratec Corporation. Thoratec 2011; Available from: www.thoratec.com

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.